Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx Group (MDXG) Gains from Investment Securities: 2011-2025

Historic Gains from Investment Securities for Mimedx Group (MDXG) over the last 9 years, with Sep 2025 value amounting to $83,000.

  • Mimedx Group's Gains from Investment Securities fell 24.55% to $83,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year increase of 12.91%. This contributed to the annual value of $2.6 million for FY2024, which is 1472.02% up from last year.
  • According to the latest figures from Q3 2025, Mimedx Group's Gains from Investment Securities is $83,000, which was down 84.22% from $526,000 recorded in Q2 2025.
  • In the past 5 years, Mimedx Group's Gains from Investment Securities registered a high of $3.2 million during Q1 2021, and its lowest value of -$1,000 during Q4 2022.
  • For the 3-year period, Mimedx Group's Gains from Investment Securities averaged around $534,182, with its median value being $110,000 (2024).
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first plummeted by 99.66% in 2023, then surged by 53,700.00% in 2024.
  • Over the past 5 years, Mimedx Group's Gains from Investment Securities (Quarterly) stood at $188,000 in 2021, then slumped by 62.97% to -$1,000 in 2022, then spiked by 13,300.00% to $132,000 in 2023, then tumbled by 77.27% to $30,000 in 2024, then decreased by 24.55% to $83,000 in 2025.
  • Its Gains from Investment Securities was $83,000 in Q3 2025, compared to $526,000 in Q2 2025 and $2.5 million in Q1 2025.